-

$undefined

N/A

(N/A)

ALIMERA SCIENCES INC NASDAQ:ALIM Alimera Sciences is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals. Alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and affect millions of people in our aging populations.

Location: 6120 Windward Pkwy Ste 290, Georgia, 30005-8897, US | Website: www.alimerasciences.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing

Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

362.9M

Cash

10.83M

Avg Qtr Burn

-1.399M

Short % of Float

4.39%

Insider Ownership

5.35%

Institutional Own.

86.54%

Qtr Updated

06/30/24

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date